Fifteen-year follow-up from the S0016 trial suggests that some patients with advanced-stage follicular lymphoma may be cured with standard chemoimmunotherapy, according to Dr. Jonathan W. Friedberg, ...
Friedberg noted that chemotherapy combined with an antibody remains a recommended treatment for patients with advanced-stage ...
Follicular lymphoma has long been considered incurable, but a study led by Wilmot Cancer Institute director Dr. Jonathan ...
A new statistical analysis of patients with follicular lymphoma, made possible by 15 years of follow-up data from a SWOG and ...
Cure rate of 42% estimated in cure modeling; highest rate seen for patients with low Follicular Lymphoma International Prognostic Index scores.
About 1 in 5 patients with B-cell lymphoma treated with loncastuximab develop skin-related adverse events, particularly ...
Twenty years. That's how long Robert Oman has been cancer-free, thanks to a clinical trial offered at the University of ...
Unlike some other forms of lymphoma, advanced stage follicular lymphoma is considered incurable. But a new analysis of long-term data on patients treated for the disease years ago with standard ...
New follicular lymphoma treatment promises lasting cure ...
BeOne Medicines AG (NASDAQ:ONC) is among the 12 best stocks to buy and hold for the next 2 years. On February 26, BeOne ...
News-Medical.Net on MSN
Fifteen-year follow up reveals cure potential in follicular lymphoma
Unlike some other forms of lymphoma, advanced stage follicular lymphoma is considered incurable. But a new analysis of long-term data on patients treated for the disease years ago with standard ...
NICE recommends epcoritamab for relapsed follicular lymphoma, offering a new option after multiple lines of therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results